Gurdatol (Tolvaptan)

Gurdatol is indicated for several clinical situations where controlled water excretion is beneficial.

• Hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
• Management of fluid overload in patients with heart failure when conventional diuretics are insufficient.
• Treatment of autosomal dominant polycystic kidney disease (ADPKD) to slow cyst growth and preserve kidney function.
• Adjunct therapy in selected cases of euvolemic or hypervolemic hyponatremia under specialist guidance.

The safety profile of Gurdatol includes both frequently observed and less common adverse reactions.

Common

• Thirst or increased urine output.
• Mild headache.
• Nausea or mild gastrointestinal discomfort.
• Elevated serum uric acid levels.

Serious

• Significant rise in serum sodium (hypernatremia).
• Liver enzyme elevations indicating potential hepatic injury.
• Severe dehydration leading to hypotension.

Before initiating Gurdatol, clinicians should evaluate several safety considerations.

• Assess baseline serum sodium and liver function tests.
• Monitor fluid balance and electrolytes regularly during therapy.
• Use caution in patients with impaired hepatic function or a history of liver disease.
• Avoid rapid correction of hyponatremia to reduce the risk of osmotic demyelination.
• Educate patients about signs of dehydration and the importance of maintaining adequate fluid intake.
• Discontinue the drug if marked hypernatremia or significant liver enzyme elevation occurs.

Gurdatol can interact with other medicines that affect water balance, electrolytes, or liver metabolism.

Avoid

• Concomitant use with other vasopressin antagonists or strong diuretics that may cause excessive free water loss.
• Potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that can increase tolvaptan exposure.

Use with caution

• CYP3A4 inducers such as rifampin, which may reduce drug effectiveness.
• NSAIDs or other nephrotoxic agents that could affect renal handling of water.
• Medications that raise serum sodium, requiring close monitoring of electrolyte status.